Business Wire

GC Pharma Announces EMA Grants Orphan Drug Designation to Hunterase ICV, The World’s First Enzyme Replacement Therapy for Mucopolysaccharidosis Type II Administered by ICV ...

YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced that the European Medicines Agency (EMA) granted orphan drug designation (ODD) to Hunterase ICV (intracerebroventricular, ...
아시아경제

Instead of Injections, 'Patch Vaccines'... Will SK Bioscience and GC Green Cross Face Off?

SK Bioscience and GC Green Cross, two major companies in domestic vaccine development, have entered the patch-type vaccine market. Known as the "pain-free injection," patch-type vaccines are ...
BMJ

Glucocorticoids in elite sport: current status, controversies and innovative management strategies—a narrative review

The use of systemic glucocorticoids (GCs), as well as local injections, continues to be a controversial issue in the sport/anti-doping community. There is widespread and legitimate use of GCs for ...